Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer

Clinical trial NCT04624399 · RECRUITING

Trial details

NCT number: NCT04624399
Sponsor: Queen Mary University of London
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urogenital Cancer

Start date: 2021-06-17
Primary completion: 2026-05-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.